Uipath Inc. logo

Uipath Inc. (PATH)

Market Closed
3 Jun, 20:00
NYSE NYSE
$
11. 67
-0.51
-4.19%
$
6.01B Market Cap
- P/E Ratio
- Div Yield
33,465,930 Volume
0.48 Eps
$ 12.18
Previous Close
Add Transaction
Day Range
11.51 12.24
Year Range
9.2 19.84
Want to track PATH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
UiPath Analysts Slash Their Forecasts After Q4 Results

UiPath Analysts Slash Their Forecasts After Q4 Results

UiPath Inc (NYSE: PATH) reported better-than-expected financial results for the fourth quarter of fiscal 2026 after the market close on Wednesday.

Benzinga | 2 months ago
UiPath Faces Selloff Despite Strong Q4 Performance and AI Momentum

UiPath Faces Selloff Despite Strong Q4 Performance and AI Momentum

UiPath (PATH) experienced a decline in stock price after reporting its Q4 results, despite exceeding expectations and raising guidance. The company emphasized s

Gurufocus | 2 months ago
UiPath stock: why sell-off makes sense despite Q4 beat and buyback

UiPath stock: why sell-off makes sense despite Q4 beat and buyback

UiPath Inc (NYSE: PATH) opened in the red this morning after the firm's muted full-year outlook tempered its Q4 beat and announcement of a new $500 million share repurchase programme. To some, the sell-off may look like an overreaction, especially given that the software company posted its first-ever profit on a GAAP basis on March 12th.

Invezz | 2 months ago
UiPath margins shine as AI fuels growth

UiPath margins shine as AI fuels growth

UiPath Inc (NYSE:PATH) reported stronger-than-expected fourth-quarter results driven by healthy subscription growth and rising profitability. The automation software company posted revenue of $481 million, up 13.6% year-over-year and above analysts' estimates of $465 million.

Proactiveinvestors | 2 months ago
UiPath Stock Sinks 6% — But It Could Still Be the Next Palantir

UiPath Stock Sinks 6% — But It Could Still Be the Next Palantir

UiPath (NYSE:PATH) declined approximately 6% in today's session, trading below $12 midday on Thursday.

247wallst | 2 months ago
UiPath, Inc. (PATH) Q4 2026 Earnings Call Transcript

UiPath, Inc. (PATH) Q4 2026 Earnings Call Transcript

UiPath, Inc. (PATH) Q4 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
UiPath: Fine Q4 Earnings, But The Bull Case Remains Uninspiring

UiPath: Fine Q4 Earnings, But The Bull Case Remains Uninspiring

UiPath's Q4 results showed 13.5% revenue growth, but this decelerated sequentially, and FY'27 guidance implies only ~10% top line growth. The new $500 million buyback is a plus for the company, but it may have less impact than bulls expect. It's still too early to say whether PATH will ultimately end up, on net, as benefitting from or being harmed by AI adoption.

Seekingalpha | 2 months ago
UiPath (PATH) Reports Q4 Earnings: What Key Metrics Have to Say

UiPath (PATH) Reports Q4 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for UiPath (PATH) give a sense of how the business performed in the quarter ended January 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 2 months ago
UiPath (PATH) Q4 Earnings and Revenues Beat Estimates

UiPath (PATH) Q4 Earnings and Revenues Beat Estimates

UiPath (PATH) came out with quarterly earnings of $0.3 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.26 per share a year ago.

Zacks | 2 months ago
UiPath Profit, Revenue Rise as AI Adoption Spreads

UiPath Profit, Revenue Rise as AI Adoption Spreads

The automation and AI platform said AI adoption from enterprise customers is moving from experimentation to scaled deployment.

Wsj | 2 months ago
Should You Buy, Sell, or Hold UiPath Stock Before Q4 Earnings?

Should You Buy, Sell, or Hold UiPath Stock Before Q4 Earnings?

PATH heads into Q4 earnings with revenues seen rising 9.7%, but weak stock momentum and neutral earnings signals leave investors weighing a hold stance.

Zacks | 2 months ago
UiPath: Why Claude-Related Fears Are Grossly Overblown (Earnings Preview)

UiPath: Why Claude-Related Fears Are Grossly Overblown (Earnings Preview)

UiPath, Inc. remains attractively valued after a 24% price drop, with macro and Claude-related fears appearing overblown given recent financial performance. PATH posted Q3 YoY revenue growth of ~16%, first-ever profitable Q3 EBIT, and robust ARR expansion, signaling resilience despite competitive AI threats. Management guides for continued ARR and sales growth in Q4, with a strong track record of beating both guidance and consensus expectations.

Seekingalpha | 3 months ago
Loading...
Load More